Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor.


Journal

ACS chemical biology
ISSN: 1554-8937
Titre abrégé: ACS Chem Biol
Pays: United States
ID NLM: 101282906

Informations de publication

Date de publication:
19 06 2020
Historique:
pubmed: 30 4 2020
medline: 13 4 2021
entrez: 30 4 2020
Statut: ppublish

Résumé

Glucagon-like peptide 1 (GLP-1) is a natural peptide agonist of the GLP-1 receptor (GLP-1R) found on pancreatic β-cells. Engagement of the receptor stimulates insulin release in a glucose-dependent fashion and increases β-cell mass, two ideal features for pharmacologic management of type 2 diabetes. Thus, intensive efforts have focused on developing GLP-1-based peptide agonists of GLP-1R for therapeutic application. A primary challenge has been the naturally short half-life of GLP-1 due to its rapid proteolytic degradation

Identifiants

pubmed: 32348108
doi: 10.1021/acschembio.0c00308
pmc: PMC7366314
mid: NIHMS1591291
doi:

Substances chimiques

Glucagon-Like Peptide-1 Receptor 0
Peptides 0
Glucagon-Like Peptide 1 89750-14-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1340-1348

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK078081
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197583
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211399
Pays : United States

Références

Bioconjug Chem. 2015 Feb 18;26(2):329-37
pubmed: 25594741
Diabetes Care. 2018 Feb;41(2):258-266
pubmed: 29246950
J Am Chem Soc. 2007 Mar 7;129(9):2456-7
pubmed: 17284038
J Biol Chem. 2010 Jan 1;285(1):723-30
pubmed: 19861722
Nat Struct Mol Biol. 2014 Jan;21(1):36-42
pubmed: 24317490
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8
pubmed: 20660316
J Med Chem. 2000 May 4;43(9):1664-9
pubmed: 10794683
Bioconjug Chem. 2016 Jul 20;27(7):1663-72
pubmed: 27327034
J Clin Invest. 2014 May;124(5):2113-24
pubmed: 24743147
Diabetes Care. 2005 May;28(5):1092-100
pubmed: 15855572
J Med Chem. 2010 Sep 9;53(17):6412-20
pubmed: 20687610
Chem Biol. 2013 Jul 25;20(7):888-902
pubmed: 23890007
Mol Cell. 2006 Oct 20;24(2):199-210
pubmed: 17052454
Cell Rep. 2018 Sep 25;24(13):3393-3403.e5
pubmed: 30257201
Cancer Cell. 2010 Nov 16;18(5):411-22
pubmed: 21075307
Nature. 2017 Jun 8;546(7657):312-315
pubmed: 28514449
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3445-54
pubmed: 23946421
Diabet Med. 2008 Feb;25(2):152-6
pubmed: 18201212
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E986-95
pubmed: 23404709
Nat Struct Mol Biol. 2014 Dec;21(12):1058-67
pubmed: 25420104
Biol Chem. 2004 Feb;385(2):169-77
pubmed: 15101559
Nat Med. 2008 Feb;14(2):144-53
pubmed: 18223655
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E886-E895
pubmed: 29339518
Org Lett. 2013 Oct 18;15(20):5318-21
pubmed: 24087900
Endocrinology. 2010 Jun;151(6):2474-82
pubmed: 20382695
Diabetologia. 1998 Mar;41(3):271-8
pubmed: 9541166
J Clin Invest. 2012 Jun;122(6):2018-31
pubmed: 22622039
Cell Metab. 2006 Mar;3(3):153-65
pubmed: 16517403
N Engl J Med. 1992 May 14;326(20):1316-22
pubmed: 1348845
Sci Transl Med. 2018 Apr 11;10(436):
pubmed: 29643228
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4140-5
pubmed: 27035989
J Am Chem Soc. 2014 Sep 17;136(37):12848-51
pubmed: 25191938
J Am Chem Soc. 2014 Sep 3;136(35):12314-22
pubmed: 25105213
Anal Chem. 2009 Oct 1;81(19):7870-5
pubmed: 19788312
Bioconjug Chem. 2005 Mar-Apr;16(2):377-82
pubmed: 15769092
Mol Cell. 2015 Mar 5;57(5):873-886
pubmed: 25684204
Lancet. 2006 Nov 11;368(9548):1696-705
pubmed: 17098089
Mol Cell. 2018 Mar 1;69(5):729-743.e7
pubmed: 29499131
Science. 2004 Sep 3;305(5689):1466-70
pubmed: 15353804
J Med Chem. 2008 May 8;51(9):2758-65
pubmed: 18412318
Nat Chem Biol. 2016 Oct;12(10):845-52
pubmed: 27547919
Nat Chem Biol. 2010 Aug;6(8):595-601
pubmed: 20562877
Cell Rep. 2015 Feb 3;10(4):497-504
pubmed: 25640178
J Med Chem. 2015 Sep 24;58(18):7370-80
pubmed: 26308095
J Med Chem. 2018 Apr 12;61(7):3218-3223
pubmed: 29528634
Nature. 2017 Jun 8;546(7657):254-258
pubmed: 28562585

Auteurs

Gregory H Bird (GH)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.

Accalia Fu (A)

Department of Cancer Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston Massachusetts 02215, United States.
Department of Cell Biology, Harvard Medical School, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, United States.

Silvia Escudero (S)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.

Marina Godes (M)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.

Kwadwo Opoku-Nsiah (K)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.

Thomas E Wales (TE)

Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.

Michael D Cameron (MD)

DMPK Core, Department of Molecular Medicine, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States.

John R Engen (JR)

Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.

Nika N Danial (NN)

Department of Cancer Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston Massachusetts 02215, United States.
Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Department of Medicine, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, United States.

Loren D Walensky (LD)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH